Page last updated: 2024-08-21

cupric sulfide and 1,4,7-triazacyclononane-n,n',n''-triacetic acid

cupric sulfide has been researched along with 1,4,7-triazacyclononane-n,n',n''-triacetic acid in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Cai, W; Chen, F; Ehlerding, EB; Goel, S; Graves, SA; Hong, H; Nickles, RJ; Orbay, H; Shi, S; Theuer, CP	1

Other Studies

1 other study(ies) available for cupric sulfide and 1,4,7-triazacyclononane-n,n',n''-triacetic acid

Article	Year
In Vivo Tumor Vasculature Targeting of CuS@MSN Based Theranostic Nanomedicine. ACS nano, 2015, Volume: 9, Issue:4 Topics: Ablation Techniques; Animals; Antineoplastic Agents; Copper; Drug Carriers; Endoglin; Female; Heterocyclic Compounds; Heterocyclic Compounds, 1-Ring; Humans; Intracellular Signaling Peptides and Proteins; Mammary Neoplasms, Experimental; Mice; Nanostructures; Neovascularization, Pathologic; Polyethylene Glycols; Porosity; Positron-Emission Tomography; Silicon Dioxide; Theranostic Nanomedicine; Tissue Distribution	2015

Article

Year

In Vivo Tumor Vasculature Targeting of CuS@MSN Based Theranostic Nanomedicine.

ACS nano, 2015, Volume: 9, Issue:4

Topics: Ablation Techniques; Animals; Antineoplastic Agents; Copper; Drug Carriers; Endoglin; Female; Heterocyclic Compounds; Heterocyclic Compounds, 1-Ring; Humans; Intracellular Signaling Peptides and Proteins; Mammary Neoplasms, Experimental; Mice; Nanostructures; Neovascularization, Pathologic; Polyethylene Glycols; Porosity; Positron-Emission Tomography; Silicon Dioxide; Theranostic Nanomedicine; Tissue Distribution

2015